Ouro Medicines

Ouro Medicines is a company based in South San Francisco, California, that states it is defining the future of treatment for people with immune-mediated diseases. Its About page describes the company as building the leading immune reset company, tackling chronic immune-mediated diseases by combining scientific expertise, a track record of advancing cell-depleting therapies through the clinic, and a robust pipeline. The company is led by founding Chief Executive Officer Jaideep Dudani, PhD, alongside a leadership team including Chief Medical Officer Neely Mozaffarian, MD, PhD, and General Counsel and Chief Operating Officer Christina Carlson, JD.

Ouro Medicines states that it was founded to build the leading immune reset company. The company tackles chronic immune-mediated diseases head-on by combining scientific expertise, a track record of advancing cell-depleting therapies through the clinic, and a robust pipeline. Jaideep Dudani, PhD, is the founding Chief Executive Officer of Ouro Medicines; he was most recently part of the founding team of Human Immunology Biosciences (HI-Bio), where he led portfolio development and strategy prior to the acquisition by Biogen, and was also the program team leader for felzartamab, an anti-CD38 monoclonal antibody currently in late-stage development for the treatment of immune-mediated kidney diseases.

Building the leading immune reset company, tackling chronic immune-mediated diseases.

1. 1Defining the future of treatment for people with immune-mediated diseases | Ouro Medicinesouromedicines.com
2. 2Leadership, Board of Directors and Investors | Ouro Medicinesouromedicines.com